AKT1 and cancer: Among them, Resistin, an adipokine related to obesity and type 2 diabetes (8), has been investigated to promote cancer cell proliferation and migration through activating intrinsic signaling pathways, like the PI3K-AKT and MAPK pathways (9, 10).